Half Year Results 

Scapa sticks to it

Scapa sticks to it

The short-term drivers that bind Scapa (SCPA) to customers of the group’s adhesive-based products can seem a little elusive. Particularly so when chief executive Heejae Chae says the industrial division – still a greater contributor to profits and sales than the healthcare business – has “never been about growth”, as he did when he walked us through half-year numbers. Consequently, Mr Chae and his team bear a greater responsibility than most public companies when it comes to managing shareholder expectations.  

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now